These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 17485579

  • 1. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS, Hellkamp AS, Halperin JL, Poole J, Anderson J, Johnson G, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2007 May 22; 115(20):2637-41. PubMed ID: 17485579
    [Abstract] [Full Text] [Related]

  • 2. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Olshansky B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, Domanski MJ, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Am Heart J; 2007 Jun 22; 153(6):1089-94. PubMed ID: 17540216
    [Abstract] [Full Text] [Related]

  • 3. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
    Olshansky B, Poole JE, Johnson G, Anderson J, Hellkamp AS, Packer D, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    J Am Coll Cardiol; 2008 Apr 01; 51(13):1277-82. PubMed ID: 18371559
    [Abstract] [Full Text] [Related]

  • 4. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH.
    J Cardiovasc Electrophysiol; 2008 Jul 01; 19(7):720-4. PubMed ID: 18373605
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2006 Jul 11; 114(2):135-42. PubMed ID: 16818817
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM, Zhang S, Chen KP, Hua W, Wang FZ, Chen X.
    Chin Med J (Engl); 2009 Apr 05; 122(7):802-6. PubMed ID: 19493393
    [Abstract] [Full Text] [Related]

  • 9. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D.
    N Engl J Med; 1995 Jul 13; 333(2):77-82. PubMed ID: 7539890
    [Abstract] [Full Text] [Related]

  • 10. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM, TOVA Investigators.
    Circulation; 2004 Mar 23; 109(11):1386-91. PubMed ID: 14993132
    [Abstract] [Full Text] [Related]

  • 11. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E, Trinquart L, Otmani A, Waintraub X, Kacet S, Clémenty J, Chatellier G, Le Heuzey JY, Evaluation Médico-Economique du Défibrillateur Automatique Implantable (EVADEF) Investigators.
    Am Heart J; 2009 Feb 23; 157(2):391-397.e1. PubMed ID: 19185651
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH, ALPHEE Study Investigators.
    Circulation; 2011 Dec 13; 124(24):2649-60. PubMed ID: 22082672
    [Abstract] [Full Text] [Related]

  • 13. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.
    Europace; 2004 Jul 13; 6(4):257-66. PubMed ID: 15172648
    [Abstract] [Full Text] [Related]

  • 14. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.
    Grimm W, Alter P, Maisch B.
    Herz; 2004 May 13; 29(3):348-52. PubMed ID: 15167963
    [Abstract] [Full Text] [Related]

  • 15. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P.
    Circulation; 2004 Jul 13; 110(2):112-6. PubMed ID: 15238454
    [Abstract] [Full Text] [Related]

  • 16. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
    Marijon E, Trinquart L, Otmani A, Leclercq C, Fauchier L, Chevalier P, Klug D, Defaye P, Lellouche N, Mansourati J, Deharo JC, Sadoul N, Anselme F, Maury P, Davy JM, Extramiana F, Hidden-Lucet F, Probst V, Bordachar P, Mansour H, Chauvin M, Jouven X, Lavergne T, Chatellier G, Le Heuzey JY, EVADEF Investigators.
    Am Heart J; 2010 Apr 13; 159(4):659-664.e1. PubMed ID: 20362726
    [Abstract] [Full Text] [Related]

  • 17. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
    Singh SN, Poole J, Anderson J, Hellkamp AS, Karasik P, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Am Heart J; 2006 Nov 13; 152(5):974.e7-11. PubMed ID: 17070171
    [Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic therapy in heart failure.
    Eckardt L, Haverkamp W, Breithardt G.
    Heart Fail Monit; 2002 Nov 13; 2(4):110-9. PubMed ID: 12634885
    [Abstract] [Full Text] [Related]

  • 19. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W, Christ M, Bach J, Müller HH, Maisch B.
    Circulation; 2003 Dec 09; 108(23):2883-91. PubMed ID: 14623812
    [Abstract] [Full Text] [Related]

  • 20. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT, Reinhall PG, Poole JE, Anderson J, Johnson G, Fletcher RD, Moore HJ, Mark DB, Lee KL, Bardy GH.
    Heart Rhythm; 2015 Oct 09; 12(10):2058-66. PubMed ID: 26096609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.